348 related articles for article (PubMed ID: 19073429)
21. Selective alterations in postsynaptic markers of chandelier cell inputs to cortical pyramidal neurons in subjects with schizophrenia.
Cruz DA; Weaver CL; Lovallo EM; Melchitzky DS; Lewis DA
Neuropsychopharmacology; 2009 Aug; 34(9):2112-24. PubMed ID: 19322171
[TBL] [Abstract][Full Text] [Related]
22. Postnatal development of prefrontal inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophrenia.
Lewis DA; Cruz D; Eggan S; Erickson S
Ann N Y Acad Sci; 2004 Jun; 1021():64-76. PubMed ID: 15251876
[TBL] [Abstract][Full Text] [Related]
23. The chandelier neuron in schizophrenia.
Lewis DA
Dev Neurobiol; 2011 Jan; 71(1):118-27. PubMed ID: 21154915
[TBL] [Abstract][Full Text] [Related]
24. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.
Gluck MR; Thomas RG; Davis KL; Haroutunian V
Am J Psychiatry; 2002 Jul; 159(7):1165-73. PubMed ID: 12091195
[TBL] [Abstract][Full Text] [Related]
25. Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia.
Maldonado-Avilés JG; Curley AA; Hashimoto T; Morrow AL; Ramsey AJ; O'Donnell P; Volk DW; Lewis DA
Am J Psychiatry; 2009 Apr; 166(4):450-9. PubMed ID: 19289452
[TBL] [Abstract][Full Text] [Related]
26. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients.
Bullock WM; Cardon K; Bustillo J; Roberts RC; Perrone-Bizzozero NI
Am J Psychiatry; 2008 Dec; 165(12):1594-603. PubMed ID: 18923069
[TBL] [Abstract][Full Text] [Related]
27. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia.
Volk DW; Pierri JN; Fritschy JM; Auh S; Sampson AR; Lewis DA
Cereb Cortex; 2002 Oct; 12(10):1063-70. PubMed ID: 12217970
[TBL] [Abstract][Full Text] [Related]
28. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.
Hashimoto T; Volk DW; Eggan SM; Mirnics K; Pierri JN; Sun Z; Sampson AR; Lewis DA
J Neurosci; 2003 Jul; 23(15):6315-26. PubMed ID: 12867516
[TBL] [Abstract][Full Text] [Related]
29. GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia.
Lewis DA
Brain Res Brain Res Rev; 2000 Mar; 31(2-3):270-6. PubMed ID: 10719153
[TBL] [Abstract][Full Text] [Related]
30. Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex.
Cruz DA; Eggan SM; Lewis DA
J Comp Neurol; 2003 Oct; 465(3):385-400. PubMed ID: 12966563
[TBL] [Abstract][Full Text] [Related]
31. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.
Kimoto S; Zaki MM; Bazmi HH; Lewis DA
JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830
[TBL] [Abstract][Full Text] [Related]
32. Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development.
Schoonover KE; Dienel SJ; Lewis DA
Biomark Neuropsychiatry; 2020 Dec; 3():. PubMed ID: 32656540
[TBL] [Abstract][Full Text] [Related]
33. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.
Sibille E; Morris HM; Kota RS; Lewis DA
Int J Neuropsychopharmacol; 2011 Jul; 14(6):721-34. PubMed ID: 21226980
[TBL] [Abstract][Full Text] [Related]
34. Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder.
Arion D; Corradi JP; Tang S; Datta D; Boothe F; He A; Cacace AM; Zaczek R; Albright CF; Tseng G; Lewis DA
Mol Psychiatry; 2015 Nov; 20(11):1397-405. PubMed ID: 25560755
[TBL] [Abstract][Full Text] [Related]
35. COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
Shukla AA; Jha M; Birchfield T; Mukherjee S; Gleason K; Abdisalaam S; Asaithamby A; Adams-Huet B; Tamminga CA; Ghose S
Schizophr Res; 2016 May; 173(1-2):94-100. PubMed ID: 27021555
[TBL] [Abstract][Full Text] [Related]
36. Localization and Diagnostic Specificity of Glutamic Acid Decarboxylase Transcript Alterations in the Dorsolateral Prefrontal Cortex in Schizophrenia.
Dowling KF; Dienel SJ; Barile Z; Bazmi HH; Lewis DA
Biol Psychiatry; 2023 Aug; 94(4):322-331. PubMed ID: 37061080
[TBL] [Abstract][Full Text] [Related]
37. Perisomatic inhibition and cortical circuit dysfunction in schizophrenia.
Lewis DA; Fish KN; Arion D; Gonzalez-Burgos G
Curr Opin Neurobiol; 2011 Dec; 21(6):866-72. PubMed ID: 21680173
[TBL] [Abstract][Full Text] [Related]
38. Expression of Transcripts Selective for GABA Neuron Subpopulations across the Cortical Visuospatial Working Memory Network in the Healthy State and Schizophrenia.
Tsubomoto M; Kawabata R; Zhu X; Minabe Y; Chen K; Lewis DA; Hashimoto T
Cereb Cortex; 2019 Jul; 29(8):3540-3550. PubMed ID: 30247542
[TBL] [Abstract][Full Text] [Related]
39. Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia.
Georgiev D; Arion D; Enwright JF; Kikuchi M; Minabe Y; Corradi JP; Lewis DA; Hashimoto T
Am J Psychiatry; 2014 Jan; 171(1):62-71. PubMed ID: 24170294
[TBL] [Abstract][Full Text] [Related]
40. Prefrontal cortical gamma-aminobutyric acid transmission and cognitive function: drawing links to schizophrenia from preclinical research.
Tse MT; Piantadosi PT; Floresco SB
Biol Psychiatry; 2015 Jun; 77(11):929-39. PubMed ID: 25442792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
